2014 - In metformin-treated type 2 diabetes mellitus, weekly dulaglutide was noninferior to daily liraglutide for HbA1c levels.

The article compares the efficacy of the drugs dulaglutide and liraglutide to metformin treated patients suffering from type-2 diabetes to reduce hemoglobin (Hb) A [1c] levels. It states the exclusion criteria of the study including pancreatitis, higher calcitonin level in serum and cardiovascular (CV) event. It concludes that weekly intake of dulaglutide did not show greater efficacy as compared to daily intake of liraglutide.